Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The tumors were seen more frequently in patients who received INCRELEX at higher than recommended doses or at doses that produced IGF-1 levels above normal for age and sex
Indian J Dermatol Venereol Leprol 2013;79:8426
In controlled research settings, Modified GRF (129) has been studied for its ability to stimulate endogenous growth hormone release through GHRH receptor activation while maintaining a short duration of activity
Reconstitution syringe a larger syringe (13 mL) for drawing and adding diluent
US$ 24.18
US$ 20.90
US$ 29.13
US$ 27.78
